4.3 Editorial Material

Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials? Comment

Journal

CLINICAL TRIALS
Volume 19, Issue 2, Pages 227-228

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/17407745211068547

Keywords

-

Funding

  1. National Institutes of Health/National Cancer Institute (NIH/NCI)
  2. Cancer Center Support Grant [P30 CA008748]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available